Differences

This shows you the differences between two versions of the page.

--- nanophthalmia [2026/07/27 11:16] – [Treatment] Scott Larson
+++ nanophthalmia [2026/07/27 12:08] (current) – Scott Larson
@@ Line 3: / Line 3: @@
 ===== Definition =====
-Nanophthalmos is a rare developmental ocular disorder characterised by a small but structurally normal eye with a significantly shortened axial length (typically ≤20.5–21.0 mm; mean ~17.6–18.1 mm), high hyperopia (often +7 to +13 diopters), a high lens-to-eye volume ratio, shallow anterior chamber, thickened sclera, and small cornea. It represents the extreme end of the hyperopia spectrum and is distinct from microphthalmos, which involves structural ocular abnormalities.
+  * Small but largely structurally normal eye
+  * Characterized by:
+    * Significantly shortened axial length (typically ≤20.5–21.0 mm; mean ~17.6–18.1 mm)
+    * [[high_hyperopia|High hyperopia]] (often +7 to +13 diopters),
+    * High lens-to-eye volume ratio
+    * Shallow anterior chamber
+    * Thickened sclera
+    * Small cornea.
+  * Distinct from [[microphthalmos|microphthalmos]], which involves structural ocular abnormalities.
 ===== Potential Causes / Genetics =====